Wild-type mice that received CD2–Tff2 bone marrow suffered the mildest colitis, while recipients of Tff2-null bone marrow had slightly more severe disease (measured by weight loss, spleen size, colonic shortening and colonic IL-1β expression) (Supplementary Fig. 7a–d). Here, IL1B is linked to colitis.